Targeted therapies for advanced non-small cell lung cancer

Related Experiment Video

Updated: May 24, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Ioannis Starakis1, Achilleas Nikolakopoulos, Elias E Mazokopakis

  • 1Patras University Hospital, 26500 Rion-Patras, Greece. istarakis@yahoo.com

Combinatorial Chemistry & High Throughput Screening
|March 14, 2012
PubMed

Insights

Targeted therapies, including anti-EGFR TKIs and anti-VEGF agents, have significantly advanced non-small cell lung cancer (NSCLC) treatment. Ongoing research explores new agents for future therapeutic strategies in advanced NSCLC.

Area of Science:

  • Oncology
  • Pharmacology
  • Medical Research

Background:

  • Advanced non-small cell lung cancer (NSCLC) management has been transformed by targeted therapies.
  • Key molecular targets include the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF).

Purpose of the Study:

  • To provide an updated review on the role of targeted agents in advanced NSCLC.
  • To present key clinical studies and future therapeutic strategies for NSCLC.

Main Methods:

  • Review of current literature on targeted agents in advanced NSCLC.
  • Analysis of clinical studies investigating EGFR and VEGF inhibitors.
  • Discussion of emerging targeted therapies and future directions.

Main Results:

  • Established targeted agents include anti-EGFR tyrosine-kinase inhibitors (TKIs) like erlotinib/gefitinib and the anti-VEGF monoclonal antibody bevacizumab.
  • Several novel agents targeting critical lung cancer pathways are in preclinical or clinical development.

Conclusions:

  • Targeted agents have significantly improved outcomes for patients with advanced NSCLC.
  • Continued research and evaluation of new agents are crucial for advancing future NSCLC treatment strategies.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...